+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neurotrophic Factor"

Neuroprotection Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Neuroprotection Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 194 Pages
  • Global
From
Neurodegenerative Drugs - Global Strategic Business Report - Product Thumbnail Image

Neurodegenerative Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 376 Pages
  • Global
From
Central Nervous System Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Central Nervous System Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 395 Pages
  • Global
From
Neuroregeneration Therapy - Global Strategic Business Report - Product Thumbnail Image

Neuroregeneration Therapy - Global Strategic Business Report

  • Report
  • June 2025
  • 480 Pages
  • Global
From
Multiple System Atrophy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Multiple System Atrophy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • January 2025
  • 180 Pages
  • Global
From
Trk (TrkB) Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Trk (TrkB) Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Alpha 1 Adrenergic Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha 1 Adrenergic Receptor Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chemotherapy Induced Peripheral Neuropathy- Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy Induced Peripheral Neuropathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Multiple System Atrophy- Pipeline Insight, 2025 - Product Thumbnail Image

Multiple System Atrophy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Chronic Spinal Cord Injury- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spinal Cord Injury- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
North America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type, Route of Administration, Treatment Type, Age Group, and Distribution Channel - Product Thumbnail Image

North America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type, Route of Administration, Treatment Type, Age Group, and Distribution Channel

  • Report
  • September 2024
  • 135 Pages
  • North America
From
Middle East & Africa Epilepsy Market Forecast to 2030 - Regional Analysis - by Type, Route of Administration, Treatment Type, Age Group, and Distribution Channel - Product Thumbnail Image

Middle East & Africa Epilepsy Market Forecast to 2030 - Regional Analysis - by Type, Route of Administration, Treatment Type, Age Group, and Distribution Channel

  • Report
  • September 2024
  • 139 Pages
  • Middle East, Africa
From
Europe Epilepsy Market Forecast to 2030 - Regional Analysis - by Type, Route of Administration, Treatment Type, Age Group, and Distribution Channel - Product Thumbnail Image

Europe Epilepsy Market Forecast to 2030 - Regional Analysis - by Type, Route of Administration, Treatment Type, Age Group, and Distribution Channel

  • Report
  • September 2024
  • 150 Pages
  • Europe
From
Asia-Pacific Epilepsy Market Forecast to 2030 - Regional Analysis - by Type, Route of Administration, Treatment Type, Age Group, and Distribution Channel - Product Thumbnail Image

Asia-Pacific Epilepsy Market Forecast to 2030 - Regional Analysis - by Type, Route of Administration, Treatment Type, Age Group, and Distribution Channel

  • Report
  • September 2024
  • 146 Pages
  • Asia Pacific
From
Rett Syndrome Market Report and Forecast 2024-2032 - Product Thumbnail Image

Rett Syndrome Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
  • Global
From
Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 267 Pages
  • Global
From
South & Central America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type, Route of Administration, Treatment Type, Age Group, and Distribution Channel - Product Thumbnail Image

South & Central America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type, Route of Administration, Treatment Type, Age Group, and Distribution Channel

  • Report
  • September 2024
  • 136 Pages
From
Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 50 Pages
  • Global
From
Beta Nerve Growth Factor - Pipeline Review, H2 2020 - Product Thumbnail Image

Beta Nerve Growth Factor - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 61 Pages
  • Global
From
Glial Cell Line Derived Neurotrophic Factor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Glial Cell Line Derived Neurotrophic Factor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • July 2023
  • 73 Pages
  • Global
From
Loading Indicator

The Neurotrophic Factor market is a subset of the Central Nervous System Drugs market, which focuses on treatments for neurological disorders. Neurotrophic Factors are proteins that promote the growth and survival of neurons, and are used to treat a variety of neurological conditions, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Neurotrophic Factors are typically administered through injections, and can be used to replace lost or damaged neurons, or to stimulate the growth of new neurons. The Neurotrophic Factor market is highly competitive, with a number of companies developing and marketing treatments. Companies in the market include Biogen, Novartis, Merck, and Pfizer. Show Less Read more